Current management of hepatocellular carcinoma

doi:10.3748/wjg.v20.i30.10223

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 30

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7318)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-10) series.

Item

Count

PDF

569

WORD

277

HTML

4263

Figures (1-1)

253

Tables (1-10)

217

Sum=5579

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

839

Download

900

Sum=1739

Aug 14, 2014 (publication date) through Nov 8, 2024

Times Cited of This Article

Times Cited (48)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 14, 2014; 20(30): 10223-10237
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10223

Current management of hepatocellular carcinoma

Parissa Tabrizian, Sasan Roayaie, Myron E Schwartz

Parissa Tabrizian, Sasan Roayaie, Myron E Schwartz, Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, New York, NY 10029, United States

Author contributions: Tabrizian P, Roayaie S and Schwartz ME contributed equally to the conception and design of data; Tabrizian P and Schwartz ME acquisition of data, drafting, and final approval of the article.

Correspondence to: Myron E Schwartz, MD, FACS, Mount Sinai Liver Cancer Program, Mount Sinai Medical Center, 1 Gustave Levy Place, Box 1104, New York, NY 10029, United States. myron.schwartz@mountsinai.org

Telephone: +1-212-6598084 Fax: +1-212-2412138

Received: January 9, 2014
Revised: May 8, 2014
Accepted: May 25, 2014
Published online: August 14, 2014
Processing time: 220 Days and 18.1 Hours

Core Tip

Core tip: Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and its incidence is rising in Western countries. The choice among therapeutic options that include liver resection, liver transplantation, locoregional, and systemic treatments must be individualized for each patient. The aim of this paper is to review the outcomes that can be achieved in the treatment of HCC with the heterogeneous therapeutic options currently available in clinical practice.